ema glp-1 vision loss recommendation ophthalmology november 2025 Warns of Risk from Semaglutide No Link Between GLP-1 Drugs

10.1038/nm.4106 Nat

GLP-1RAs may improve these metabolic outcomes while modulating inflammatory pathways that contribute to muscle loss and the development of sarcopenia

TNF is an immune signaling molecule that plays a pivotal role in modulating synaptic mechanisms in the brain

IBD is a multifactorial disease where activation of inflammatory cells are thought to play a key role for its development, however the role of ROS and subsequent oxidative stress as a pathological factor for IBD has not been well defined

In ATTAIN-1, adverse event-related discontinuation rates were 5.3% with orforglipron 6 mg, 7.6% with 12 mg, and 10.3% with 36 mg, compared with 2.7% with placebo